pandem
stress
healthcar
care
system
throughout
world
understand
clinic
progress
case
key
public
health
prioriti
inform
optim
resourc
alloc
emerg
use
data
shenzhen
china
case
monitor
hospit
symptom
profil
clinic
lab
result
avail
start
earli
stage
clinic
cours
character
clinic
progress
case
determin
import
predictor
faster
clinic
progress
key
clinic
event
longer
use
medic
resourc
epidemiolog
demograph
laboratori
clinic
outcom
data
extract
electron
medic
record
found
progress
sever
stage
develop
acut
respiratori
distress
syndrom
admit
intens
care
unit
icu
progress
averag
day
ci
day
ci
day
ci
symptom
onset
respect
estim
patient
admit
icu
remain
averag
day
ci
averag
time
ventil
day
ci
among
requir
mechan
ventil
median
length
hospit
stay
day
ci
mild
moder
case
progress
sever
stage
increas
day
ci
requir
icu
admiss
clear
character
clinic
progress
inform
plan
healthcar
resourc
alloc
outbreak
provid
basi
help
assess
effect
new
treatment
therapeut
epidem
coronaviru
led
million
infect
death
month
first
case
detect
caus
sever
shortag
essenti
medic
suppli
equip
medic
staff
hospit
bed
complementari
data
epicent
like
wuhan
china
lombardi
itali
data
place
healthcar
capac
exceed
patient
treat
earli
free
charg
potenti
shed
light
near
complet
clinic
trajectori
case
clear
character
clinic
trajectori
current
standard
care
inform
plan
healthcar
resourc
alloc
outbreak
provid
basi
help
assess
effect
new
treatment
therapeut
use
rich
data
clinic
progress
case
diagnos
treat
design
hospit
shenzhen
china
clinic
confirm
case
includ
sizabl
portion
detect
contact
trace
requir
hospit
isol
purpos
regardless
clinic
present
symptom
profil
dataset
allow
us
examin
clinic
progress
case
without
consider
select
bia
typic
seen
hospitalbas
studi
estim
time
symptom
onset
key
clinic
event
first
clinic
diagnosi
progress
sever
clinic
stage
develop
acut
respiratori
distress
syndrom
ard
admiss
critic
care
unit
icu
discharg
also
estim
durat
hospit
icu
ventil
determin
key
predictor
faster
clinic
progress
seri
clinic
event
longer
use
healthcar
resourc
singlecentr
observ
studi
conduct
shenzhen
third
peopl
hospit
design
hospit
treat
patient
shenzhen
prospect
collect
data
patient
diagnos
hospit
shenzhen
januari
march
regardless
clinic
sever
symptom
profil
epidemiolog
demograph
laboratori
clinic
outcom
data
extract
electron
medic
record
use
standardis
data
collect
form
inform
updat
april
data
review
multipl
review
bs
jc
jz
pz
disagr
review
resolv
consult
attend
physician
jm
data
patient
sever
critic
clinic
assess
extract
attend
physician
jm
review
review
ch
ensur
data
qualiti
obtain
inform
demograph
characterist
mode
detect
date
onset
symptom
date
symptom
onset
admiss
selfreport
date
symptom
onset
admiss
record
attend
physician
clinic
sever
defin
base
guidelin
issu
nation
health
commiss
peopl
republ
china
sever
definit
gener
consist
time
see
supplement
tabl
guidelin
version
record
clinic
sever
initi
diagnosi
date
sever
progress
clinic
sever
assess
daili
mild
moder
assess
twice
day
sever
critic
date
icu
admiss
discharg
record
well
date
begin
end
invas
ventil
use
patient
elig
discharg
hospit
transfer
noncovid
ward
treatment
met
follow
fever
day
drastic
improv
respiratori
symptom
pulmonari
imag
show
signific
reduct
inflamm
two
consecut
neg
rtpcr
result
respiratori
sampl
conduct
one
day
apart
count
time
noncovid
ward
treatment
relat
complic
toward
durat
hospit
record
patient
selfreport
medic
histori
see
tabl
list
baselin
comorbid
review
laboratori
result
creat
binari
variabl
indic
presenc
abnorm
date
abnorm
detect
see
complet
list
lab
indic
abnorm
cutoff
xray
comput
tomographi
ct
result
extract
radiolog
examin
record
lowest
cycl
threshold
valu
avail
rtpcr
test
date
test
perform
also
record
complic
develop
hospit
primari
endpoint
studi
includ
patient
time
symptom
onset
clinic
progress
beyond
moder
stage
icu
admiss
invas
ventil
use
discharg
also
examin
endpoint
includ
time
drop
time
develop
ard
estim
cumul
incid
develop
key
clinic
event
presenc
compet
risk
ie
death
hospit
discharg
use
aalenjohansen
estim
outcom
includ
progress
sever
stage
low
ratio
ard
icu
admiss
use
invas
ventil
hospit
discharg
estim
patient
durat
hospit
calcul
area
cumul
incid
hospit
discharg
death
estim
use
aalenjohansen
estim
addit
estim
time
patient
admit
icu
ultim
spent
icu
area
cumul
incid
function
icu
entri
icu
exit
among
admit
icu
treat
death
icu
icu
discharg
composit
event
estim
cumul
incid
icu
exit
similarli
estim
durat
invas
ventil
use
among
patient
requir
ventil
area
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
cumul
incid
function
ventil
initi
ventil
discontinu
treat
death
ventil
use
withdraw
ventil
support
composit
event
estim
ventil
discontinu
compar
time
state
estim
use
nonparametr
approach
describ
time
estim
use
parametr
acceler
failur
time
model
examin
improv
precis
seen
invok
parametr
approach
see
text
detail
method
use
bootstrap
simul
construct
confid
interv
bootstrap
simul
time
recoveri
time
ard
bootstrap
simul
time
icu
entrydischarg
ventil
usewithdraw
confid
interv
percentil
distribut
point
estim
bootstrap
sampl
use
compet
risk
regress
accord
method
fine
gray
estim
subdistribut
hazard
ratio
compar
rate
clinic
progress
subgroup
defin
priori
see
tabl
list
subgroup
compar
rate
clinic
progress
sever
stage
icu
admiss
ard
hospit
discharg
subgroup
except
model
time
hospit
discharg
outcom
hospit
discharg
death
treat
compet
event
end
studi
administr
censor
still
treatment
use
flexibl
approach
stratifi
case
three
risk
strata
purpos
visual
differ
clinic
trajectori
construct
random
surviv
forest
model
rsf
divid
case
low
medium
high
risk
group
base
tertil
rsf
outofbag
predict
candid
predictor
use
rsf
model
includ
demograph
inform
baselin
comorbid
symptom
profil
lab
ct
result
within
day
symptom
onset
hospit
discharg
treat
compet
event
four
death
occur
case
progress
beyond
sever
stage
thu
treat
compet
event
calcul
auc
time
sinc
symptom
onset
tauc
provid
measur
model
perform
across
possibl
classif
threshold
base
observ
number
case
enter
sever
stage
time
point
fit
tree
consid
random
split
candid
split
variabl
use
logrank
test
split
function
fourhundr
twenti
case
admit
hospit
shenzhen
third
peopl
hospit
januari
march
figur
fifteen
percent
case
detect
contact
trace
tabl
averag
first
clinic
diagnosi
occur
day
ci
hospit
occur
day
ci
symptom
onset
case
approxim
equal
number
male
femal
tabl
larg
portion
age
major
detect
symptombas
surveil
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
case
least
one
selfreport
comorbid
admiss
hypertens
diabet
preval
fever
cough
sputum
product
common
initi
symptom
patient
show
fever
cough
sputum
product
within
day
initi
symptom
onset
see
supplement
figur
onset
time
distribut
symptom
patient
never
fever
patient
never
cough
initi
clinic
assess
patient
clinic
mild
vast
major
moder
patient
clinic
sever
critic
figur
estim
proport
initi
mild
moder
case
stage
mildmoder
sever
icu
death
discharg
time
follow
symptom
onset
take
account
patient
transit
stage
figur
total
number
patient
sever
stage
reach
peak
day
symptom
onset
among
patient
classifi
mild
moder
time
initi
assess
progress
sever
stage
ci
progress
sever
stage
within
day
symptom
onset
ci
progress
within
day
figur
progress
sever
stage
progress
averag
day
ci
symptom
onset
among
patient
classifi
mild
moder
time
initi
assess
develop
ard
ci
develop
ard
within
day
symptom
onset
ci
within
day
develop
ard
develop
ard
averag
day
ci
symptom
onset
april
patient
admit
icu
among
patient
requir
invas
mechan
ventil
support
patient
die
patient
die
initi
hospit
discharg
viral
clearanc
patient
remain
hospit
critic
condit
estim
among
patient
classifi
mild
moder
time
initi
assess
ci
patient
requir
icu
admiss
within
day
symptom
onset
patient
requir
mechan
ventil
support
requir
icu
admiss
admit
icu
averag
day
ci
symptom
onset
use
data
patient
admit
icu
estim
averag
time
icu
day
ci
tabl
use
data
patient
requir
mechan
ventil
support
estim
averag
time
ventil
day
ci
median
length
hospit
stay
day
ci
mild
moder
case
progress
sever
stage
increas
day
ci
case
reach
sever
stage
enter
icu
day
ci
case
requir
icu
admiss
note
patient
shenzhen
requir
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
hospit
week
isol
case
initi
mild
moder
discharg
within
day
hospit
within
day
durat
hospit
mild
moder
case
like
inflat
result
patient
clinic
mild
time
initi
assess
stay
mild
discharg
figur
identifi
prioridefin
patient
characterist
associ
faster
clinic
progress
found
hypertens
diabet
baselin
strongli
associ
faster
clinic
progress
variou
clinic
event
includ
progress
sever
stage
ci
hypertens
ci
diabet
develop
ard
ci
hypertens
ci
diabet
icu
admiss
ci
hypertens
ci
diabet
tabl
baselin
comorbid
also
associ
higher
rate
clinic
progress
event
tabl
although
mani
lab
abnorm
measur
within
day
symptom
onset
strongli
predict
faster
clinic
progress
includ
low
lymphocyt
count
low
platelet
count
high
concentr
creactiv
protein
high
concentr
ddimer
notabl
low
ratio
close
symptom
onset
strongli
associ
faster
clinic
progress
observ
time
ci
increas
subdistribut
hazard
icu
admiss
among
earli
measur
low
ratio
tabl
older
age
one
import
predictor
faster
clinic
progress
tabl
four
patient
die
male
age
half
case
age
progress
sever
critic
stage
tabl
although
vast
major
age
progress
beyond
moder
stage
case
younger
age
group
becam
clinic
sever
critic
none
known
underli
comorbid
sex
strongli
associ
clinic
progress
case
though
differ
sex
mostli
driven
differ
among
older
patient
observ
signific
differ
time
icu
admiss
male
femal
age
shr
ci
compar
male
refer
femal
tabl
figur
howev
observ
noteabl
differ
progress
requir
icu
admiss
male
femal
age
male
older
age
group
increas
subdistribut
hazard
icu
admiss
compar
femal
age
group
ci
despit
similar
sexspecif
age
distribut
age
group
male
mean
iqr
vs
femal
mean
iqr
tabl
differ
baselin
comorbid
older
male
femal
explain
dispar
adjust
underli
comorbid
subdistribut
hazard
ratio
remain
unchang
tabl
similarli
found
male
age
lower
rate
hospit
discharg
compar
femal
age
group
signific
differ
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
sex
younger
age
group
figur
howev
find
signific
dispar
clinic
progress
sever
stage
develop
ard
sex
age
group
tabl
use
linear
regress
found
minimum
rtpcr
cycl
threshold
valu
sever
case
significantli
lower
mild
case
adjust
time
sampl
collect
refer
symptom
onset
observ
gener
trend
lower
minimum
cycl
threshold
valu
patient
sever
clinic
present
patient
older
age
group
though
associ
age
statist
signific
figur
base
random
surviv
forest
result
import
predictor
faster
progress
sever
stage
low
ratio
low
platelet
count
high
creactiv
protein
concentr
figur
observ
differ
clinic
trajectori
patient
risk
group
figur
highlight
effect
risk
stratif
produc
rsf
model
lowrisk
group
case
requir
icu
admiss
ci
case
becam
sever
within
day
symptom
onset
wherea
highrisk
group
estim
ci
case
becam
sever
ci
requir
icu
admiss
within
day
symptom
onset
one
case
requir
icu
admiss
classifi
highrisk
group
estim
durat
icu
highrisk
group
day
ci
tabl
figur
risk
stratif
produc
rsf
model
exclud
lab
ct
result
candid
predictor
also
differenti
clinic
trajectori
patient
well
figur
figur
cd
analysi
clinic
data
patient
shenzhen
third
peopl
hospit
provid
insight
clinic
progress
case
start
earli
cours
infect
estim
proport
case
sever
stage
day
follow
symptom
onset
present
patient
characterist
associ
faster
clinic
progress
longer
use
medic
resourc
treatment
free
charg
hospit
case
mandatori
shenzhen
expect
result
strongli
affect
select
bia
plagu
mani
hospitalbas
studi
therefor
result
provid
clear
pictur
composit
case
citi
term
diseas
sever
clinic
trajectori
case
although
healthcar
resourc
shenzhen
rare
overwhelm
influx
patient
show
trajectori
clinic
progress
case
shenzhen
similar
trajectori
wuhan
china
mean
time
icu
admiss
mean
time
develop
acut
respiratori
distress
syndrom
around
day
patient
characterist
previous
report
associ
ard
death
includ
hypertens
diabet
variou
lab
result
also
highli
predict
faster
clinic
progress
variou
key
clinic
event
includ
progress
sever
stage
ard
icu
admiss
previou
studi
report
case
male
median
age
higher
percentag
men
requir
icu
care
show
differ
clinic
progress
male
femal
primarili
driven
stark
differ
older
age
group
independ
differ
baselin
comorbid
studi
number
limit
date
symptom
onset
extract
physician
note
record
explicitli
ascertain
inform
symptom
onset
date
symptom
onset
could
determin
assum
onset
date
date
initi
diagnosi
perform
sensit
analys
assess
patient
characterist
clinic
progress
sever
stage
icu
admiss
result
remain
qualit
tabl
also
perform
rsf
analys
use
symptom
profil
lab
result
within
day
initi
diagnosi
candid
predictor
integr
auc
remain
rel
unchang
figur
estim
durat
icu
stay
ventil
use
somewhat
imprecis
like
due
small
sampl
size
reach
critic
stage
even
though
estim
durat
use
nonparametr
approach
show
improv
precis
compar
time
estim
use
parametr
acceler
failur
time
model
estim
time
within
subgroup
need
interpret
caution
small
sampl
size
tabl
final
associ
present
clinic
progress
patient
characterist
interpret
causal
given
variat
treatment
numer
confound
account
studi
demonstr
patient
characterist
near
symptom
onset
tremend
potenti
inform
triag
group
patient
risk
set
differ
outlook
clinic
progress
rsf
model
perform
well
base
outofbag
predict
figur
text
would
highli
cautiou
triag
patient
set
use
import
variabl
identifi
due
limit
sampl
size
howev
import
first
step
toward
applic
triag
risk
screen
tool
well
record
data
clinic
cours
patient
becom
avail
strateg
respons
alloc
medic
resourc
ongo
outbreak
may
also
benefit
dynam
risk
score
system
incorpor
new
patientlevel
lab
symptom
inform
updat
time
conclus
provid
quantit
character
clinic
progress
patient
begin
earli
clinic
stage
estim
form
basi
assess
effect
new
treatment
inform
plan
healthcar
resourc
alloc
outbreak
tabl
demograph
characterist
surveil
method
baselin
comorbid
symptom
profil
lab
ct
result
highest
clinic
sever
assess
comorbid
selfreport
admiss
tabl
estim
length
hospit
stay
durat
icu
length
invas
ventil
use
estim
durat
icu
among
admit
icu
estim
durat
ventil
among
requir
ventil
three
case
whose
initi
sever
either
sever
critic
exclud
estim
riskgroup
specif
durat
hospit
stay
durat
icu
durat
ventil
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
tabl
associ
demograph
characterist
baselin
comorbid
initi
symptom
initi
lab
result
rate
clinic
progress
sever
stage
acut
respiratori
distress
syndrom
icu
admiss
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
figur
clinic
progress
within
day
follow
symptom
onset
case
mild
moder
initi
assess
b
case
three
risk
subgroup
obtain
random
surviv
forest
see
result
list
predictor
top
bottom
four
curv
show
timevari
proport
admit
case
discharg
ie
still
hospit
die
hospit
sever
icu
die
icu
die
die
success
differ
four
curv
day
symptom
onset
highlight
distinct
color
show
daili
composit
case
four
stage
mildmoder
sever
icu
die
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
figur
cumul
incid
clinic
event
differ
age
sex
cumul
incid
advanc
sever
stage
drop
requir
icu
admiss
develop
acut
respiratori
distress
syndrom
b
cumul
incid
icu
admiss
age
group
sex
c
cumul
incid
hospit
discharg
age
group
sex
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
